The Shape of the Messenger: Using Protein Structure Information to Design Novel Cytokine-based Therapeutics
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2113-2129
Author(s):
Catherine H. Schein
Rational Design and Development of RDP58
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2217-2229
Author(s):
Suhasini Iyer, Roger Lahana and Roland Buelow
Agents Targeting Ras Signaling Pathway
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2259-2267
Author(s):
J. E. Dancey
The Design of Clinical Trials for New Molecularly Targeted Compounds: Progress and New Initiatives
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2279-2284
Author(s):
Lesley Seymour
Kringle Structures and Antiangiogenesis
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
667-681
Author(s):
Yihai Cao, Renhai Cao and Niina Veitonmaki
Vitamin D3 and Vitamin D3 Analogues as an Adjunct to Cancer Chemotherapy and Radiotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
683-690
Author(s):
David A. Gewirtz, Mona S. Gupta and Sujatha Sundaram
Flavonoids as Anticancer Agents: Structure-Activity Relationship Study
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
691-714
Author(s):
M. Lopez-Lazaro
Styrene Maleic Acid Neocarzinostatin Treatment for Hepatocellular Carcinoma
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
715-726
Author(s):
Shintaro Abe and Makoto Otsuki
Signal Transduction Inhibitors as Radiosensitizers
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
727-742
Author(s):
A. Tenzer, D. Zingg, O. Riesterer, V. Vuong, S. Bodis and M. Pruschy
Preface
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
i-i
Author(s):
Giovanni Capranico